Cholestatic hepatitis with intravenous ceftriaxone
نویسندگان
چکیده
منابع مشابه
Azithromycin-induced cholestatic hepatitis
Since its introduction >20 years ago, Azithromycin has been widely used owing to its broad spectrum and good tolerability, especially when used for <7 days. In literature, there are only very few, sporadic reports available of patients developing cholestatic hepatitis following treatment with it. The current case study describes a 69-year old patient, with a medical history that included signif...
متن کاملNeonatal lupus erythematosus with cholestatic hepatitis.
Neonatal lupus erythematosus is an uncommon passive autoimmune disease in which there is transplacental passage of anti-Ro/SSA and/or anti-La/SSB or anti-U1RNP maternal autoantibodies. Its common clinical manifestations include cardiac disease, notably congenital heart block, cutaneous lupus lesions, and hematologic problems. During the past decade, it has become clear that hepatobiliary diseas...
متن کاملFenofibrate-induced acute cholestatic hepatitis.
Fenofibrate-induced acute or chronic hepatitis is rare, and only 11 reports from French, Italian or Spanish literature have been published up to date. We report a case of fenofibrate-induced acute cholestatic hepatitis. To the best of our knowledge, this is the first one reported in Taiwan. A 61-year-old man developed acute cholestatic hepatitis after taking fenofibrate 100 mg tid for 10 days. ...
متن کاملacute cholestatic hepatitis associated with teucrium polium
diabetes mellitus (dm) is a metabolic disorder resulting from a defect in insulin secretion, insulin action or both. despite the fact that it has a worldwide high prevalence, morbidity and mortality, it is regarded as a non–curable but controllable disease. in addition to different synthetic drugs, plant remedies and dietary traditions play an effective role in treatment. teucrium polium l. is ...
متن کاملCholestatic Hepatitis with Small Duct Injury Associated with Celecoxib
Drug-induced liver injury (DILI) is a common clinical entity but is underreported due to various reasons. Cyclooxygenase-2 inhibitors like Celecoxib have been proven to be associated with lesser incidence of adverse drug reactions compared to other nonsteroidal anti-inflammatory drugs (NSAID). However, Celecoxib has been rarely reported to be associated with cholestasis and hepatitis. We presen...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Pharmacology
سال: 2011
ISSN: 0253-7613
DOI: 10.4103/0253-7613.83133